A client presents to the emergency department with complaints of sharp chest pain and palpitations. Review the electronic health record. Complete the diagram by dragging from the choices below to specify what condition the client is most likely experiencing, two actions the nurse should take to address that condition, and two parameters the nurse should monitor to assess the client's progress.

A cardiac tamponade is a life-threatening condition caused by accumulation of fluid in the pericardial sac leading to impaired ventricular filling and reduced cardiac output. Classic findings include hypotension, jugular vein distention, muffled heart sounds (Beck’s triad), tachycardia, and signs of shock such as weak pulses and hypoxia. In a client with a recent pacemaker insertion, tamponade can occur due to procedural perforation or pericardial irritation. Immediate intervention is required to prevent cardiovascular collapse. Rationale for correct choices: • Cardiac tamponade: The client presents with hypotension (86/56 mmHg), tachycardia, muffled heart sounds, jugular vein distention, and weak pulses, all classic signs of Beck’s triad and poor cardiac output. The recent pacemaker placement increases risk for cardiac perforation and pericardial effusion. These findings strongly indicate cardiac tamponade, a medical emergency requiring immediate decompression. The normal troponin and BNP further support a non-ischemic, non-heart failure cause. • Assist with pericardiocentesis: Pericardiocentesis is the definitive emergency treatment for cardiac tamponade. It removes excess pericardial fluid, relieving pressure on the heart and restoring ventricular filling and cardiac output. Without this intervention, the patient is at risk for rapid hemodynamic collapse. The nurse’s role includes preparing equipment, monitoring vitals, and assisting the provider. • Administer oxygen 3L/NC: Oxygen therapy improves tissue oxygenation in the setting of decreased cardiac output and hypoxia (SpO₂ 88%). Although oxygen does not treat the underlying cause, it supports vital organ perfusion during hemodynamic instability. This is an immediate supportive intervention to reduce cellular hypoxia while definitive treatment is performed. It is appropriate in all forms of shock and tamponade. • ECG for ventricular fibrillation: Continuous ECG monitoring is essential because cardiac tamponade can lead to severe dysrhythmias, including ventricular tachycardia or ventricular fibrillation due to myocardial ischemia. Monitoring allows early detection of life-threatening rhythm changes during deterioration or intervention. It is a critical parameter for evaluating cardiac stability in real time. • Pericardial catheter drainage: If pericardiocentesis is performed and a drain is placed, monitoring output is essential to assess ongoing bleeding or fluid accumulation. Increasing drainage may indicate continued effusion or hemorrhage, while sudden cessation may indicate catheter blockage. This helps evaluate effectiveness of treatment and detect complications early. Rationale for incorrect choices: • Heart failure: This typically presents with pulmonary congestion such as crackles, peripheral edema, weight gain, and elevated BNP levels. In this client, BNP is within normal range (88 pg/mL), and there is no evidence of fluid overload such as lung crackles or edema. The presence of muffled heart sounds, jugular vein distention, hypotension, and recent pacemaker insertion strongly points instead to obstructive shock rather than pump failure. • Myocardial infarction: This would typically present with elevated cardiac biomarkers (such as troponin), ischemic ECG changes, and often radiating chest pain. In this case, troponin is normal (0.01 ng/mL), and there is no evidence of myocardial ischemia provided. Additionally, muffled heart sounds and jugular vein distention are not characteristic findings of MI. The clinical signs are more consistent with impaired cardiac filling due to pericardial fluid accumulation rather than coronary artery occlusion. • Myocarditis: This is an inflammatory condition of the heart muscle, often associated with viral illness, elevated troponin levels, and reduced cardiac function. This client does not show elevated cardiac enzymes or signs of systemic infection or inflammation. The acute onset of hypotension, JVD, muffled heart sounds, and recent pacemaker placement are more consistent with mechanical compression of the heart rather than myocardial inflammation. • Administer prednisone: Prednisone is a corticosteroid used for inflammatory or autoimmune conditions but is not indicated in acute cardiac tamponade. It does not relieve pericardial fluid accumulation or improve hemodynamic instability. Using steroids would delay life-saving intervention. • Administer furosemide: Furosemide is a diuretic used in fluid overload conditions such as heart failure, but this client’s problem is not systemic fluid overload. Cardiac tamponade is due to localized pericardial fluid causing mechanical compression, not volume excess. Diuretics would not relieve the pressure on the heart and may worsen hypotension. • Administer nitroglycerin: Nitroglycerin reduces preload and is used in ischemic chest pain or heart failure with hypertension. In cardiac tamponade, the issue is impaired ventricular filling due to external compression, not coronary vasoconstriction. Nitroglycerin could further lower blood pressure and worsen shock. • Daily weight: Daily weight is primarily used to monitor fluid status in conditions such as heart failure, where systemic fluid retention is present. In cardiac tamponade, the issue is not total body fluid overload but localized pericardial fluid causing cardiac compression. Therefore, daily weight does not accurately reflect disease progression or response to treatment in this condition. More direct hemodynamic and procedural monitoring is required. • Every 5-minute pain assessment: While chest pain is a symptom in many cardiac conditions, frequent pain reassessment every 5 minutes is more relevant to myocardial infarction management. In cardiac tamponade, the priority is monitoring hemodynamic stability rather than pain severity, which is not the primary driver of deterioration. Clinical decline is better reflected by blood pressure, jugular venous pressure, and cardiac output rather than pain scores alone. • Active viral disease: Active viral disease is not a monitoring parameter but rather a possible etiologic factor in conditions like myocarditis. It does not provide real-time information about the client’s current hemodynamic status or response to treatment in cardiac tamponade. Monitoring viral status is irrelevant to acute management of pericardial fluid accumulation.